Company Directory

Human tissue research CRO supporting preclinical drug discovery

Pharmagene Discovery Services is a UK contract research organisation specialising in laboratory-based research services using consented human tissue and primary human cells. The company provides tailored assay design and development across target expression, spatial biology, functional cellular biology, bioassays, and biotherapeutic safety testing. Operating under GLP conditions and licensed by the UK Human Tissue Authority, Pharmagene maintains an in-house human tissue biorepository and offers sample processing and biostorage services to biopharma clients globally.

Pharmaceutical formulation development and clinical manufacturing services

SGS Quay Pharma is a contract development and manufacturing organisation providing formulation development, analytical services, and clinical trial manufacturing for pharmaceutical and biotechnology companies. The company specialises in dosage form design for APIs with challenging solubility and bioavailability profiles, and in modified and controlled release formulations. Operating from a MHRA and FDA-approved facility in North Wales, it supports clients from preclinical stage through to Phase III and commercial manufacture.

Clinical trial delivery for Alzheimer's and neurodegenerative disease

Scottish Brain Sciences is a contract research organisation building and operating clinical trial infrastructure for Alzheimer's disease and other neurodegenerative conditions. Working with pharmaceutical sponsors, it delivers trial screening, patient recruitment, and study conduct at dedicated clinical sites in Edinburgh and Aberdeen. Its capabilities span blood biomarker testing, neuroimaging, and cognitive assessment, enabling early detection and participant identification for disease-modifying therapy trials.

Endometrial biology platform for implantation failure and miscarriage

Sita Bio is a London-based biotech developing a first-trimester biology platform to investigate embryo implantation failure and recurrent miscarriage. The company combines endometrial phenotyping and molecular state mapping with human uterine models incorporating hormone-responsive epithelium, stromal ECM, perfusable vasculature and immune elements. Its long-term goal is to enable precision protocol selection for IVF clinics and to identify therapeutic candidates for early pregnancy loss.

Human biospecimen and disease-state plasma supplier

Logical Biological is a UK supplier of human biological materials including disease-state and normal-donor serum, plasma, swabs, tissues, PBMCs, and biofluids to IVD manufacturers and life science researchers worldwide. The company sources specimens through a global network of donor centres and blood banks across five continents, and provides customised materials including bulk engineered disease-state plasma, with capabilities in protein purification and sample processing. Customers include diagnostic test developers and IVD control manufacturers.

Enzymatic wound debridement therapy derived from maggot biology

SolasCure is a biotechnology company developing a recombinant enzyme-based hydrogel for the treatment of chronic wounds. The lead product contains a protease cloned from medical maggots that degrades non-viable wound tissue including fibrin, elastin, and collagen to prepare the wound bed for healing. The product is in Phase II clinical development for venous leg ulcers, with anti-biofilm activity as a secondary indication under investigation.

Oncology biotech developing peptide therapeutics and diagnostics

ValiRx is a UK-listed biopharmaceutical company focused on the development of oncology therapeutics and companion diagnostics. The company selects and incubates novel drug candidates, including peptide-based compounds targeting prostate cancer, endometriosis, and other solid tumours, progressing them from preclinical evaluation towards clinical development and partnering. Through its subsidiary Inaphaea BioLabs, ValiRx also offers translational drug discovery services, including cell-based assays and patient-derived cell models, to academic and industry researchers.

Full service clinical trial and real-world evidence study management

O4 Research is a Belfast-based clinical research and site management organisation delivering full service and functional clinical trial services to pharmaceutical, biotechnology and consumer health companies across the UK, Ireland and Europe. The company specialises in late-phase clinical trials and non-interventional real-world evidence studies, offering services spanning concept development, study design, patient recruitment, clinical monitoring, regulatory submissions, medical writing, and data management.

Specialist CRO for rare disease drug development and commercialisation

TMC Pharma Services is a contract research organisation specialising in drug development support for rare and orphan diseases. The company serves small and mid-sized biotech and biopharma clients across the full development lifecycle, providing regulatory affairs, clinical development, pharmacovigilance, medical services, quality management, and drug commercialisation services including marketing authorisation holder functions. Therapeutic areas of focus include oncology, rare neurological disorders, respiratory disease, and haematology.

Takeda's UK clinical development and drug discovery operations

Takeda UK encompasses the British operations of Takeda Pharmaceutical Company, one of the world's largest biopharmaceutical companies. The London-based Takeda Development Centre Europe leads clinical development, regulatory affairs, and medical affairs across oncology, neuroscience, gastrointestinal disease, rare diseases, and vaccines. Takeda Cambridge, based at Cambridge Science Park, conducts target-based drug discovery research in CNS disorders and metabolic diseases.

Ex-vivo organ perfusion services for preclinical drug evaluation

Pebble Bio is a contract research organisation providing ex-vivo organ and tissue perfusion services as an alternative to large animal experimentation. Using living organ systems maintained under physiological conditions, the company evaluates the safety, efficacy, and pharmacology of novel therapeutics, biomedical materials, and medical devices. Services are structured as fee-per-project packages supporting assets from early-stage evaluation through to regulatory submission.

Full-service CRO and pharmacovigilance services for biopharma

Ergomed is a global contract research organisation providing clinical development, pharmacovigilance, and regulatory compliance services to the pharmaceutical and biotechnology industries. Operating across more than 100 countries, the group manages Phase I to IV clinical trials with particular depth in oncology and rare disease programmes. Its portfolio of service brands includes Ergomed Clinical Research, PrimeVigilance for post-marketing drug safety, and ADAMAS Consulting for GxP auditing.